Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Published:2018-09-28 Issue:4 Volume:33 Page:884-892
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Bhojwani Deepa^ORCID,Sposto Richard,Shah Nirali N.,Rodriguez Vilmarie,Yuan Constance,Stetler-Stevenson Maryalice,O’Brien Maureen M.,McNeer Jennifer L.,Quereshi Amrana,Cabannes Aurelie,Schlegel Paul,Rossig Claudia,Dalla-Pozza Luciano,August Keith,Alexander Sarah,Bourquin Jean-Pierre,Zwaan Michel,Raetz Elizabeth A.,Loh Mignon L.,Rheingold Susan R.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0265-z.pdf

Reference20 articles.

1. Bhojwani D, Pui CH. Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol. 2013;14:e205–17.

2. Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis R, et al. Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia. 2018. https://doi.org/10.1038/s41375-018-0094-0 . [Epub ahead of print].

3. Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol. 2010;28:648–54.

4. Dahl J, Marx K, Jabbour E. Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia. Expert Rev Hematol. 2016;9:329–34.

5. Tedder TF, Poe JC, Haas KM. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction. Adv Immunol. 2005;88:1–50.

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease‐burden‐adapted immunotherapy protocol for primary refractory or high‐risk relapsed pediatric acute lymphoblastic leukemia;HemaSphere;2024-07-29

2. Outcomes of children treated for relapsed or refractory acute lymphoblastic leukemia: A single tertiary care center experience;Cancer Reports;2024-07

3. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

4. Veno-Occlusive Disease: A Life-Saving Novel Approach With Plasma Exchange, IVIG, and Steroid, Without Defibrotide;Journal of Pediatric Hematology/Oncology;2024-05-30

5. Inotuzumab Ozogamicin: First Pediatric Approval;Pediatric Drugs;2024-05-23